The drug industry wants us to think Martin Shkreli is a rogue CEO. He isn’t.

Three millennia ago in ancient Greece, a plant called autumn crocus was used to treat gout. A pill form of the active ingredient, colchicine, has been used to treat the illness in the United States since the 19th century. But six years ago, a clinical trial showed the drug's safety and efficacy and URL Pharma was granted the exclusive marketing rights for a drug that had previously sold for 9 cents a tablet. The price shot up to $4.85 -- a more than 5,000 percent increase.
Read more: http://ift.tt/1LWVsPJ